Dr. Leonid Volfinzon, M.D

NPI: 1952403933
Total Payments
$1,919
2024 Payments
$404.49
Companies
10
Transactions
39
Medicare Patients
10,889
Medicare Billing
$1.5M

Payment Breakdown by Category

Food & Beverage$1,919 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,919 39 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $739.65 11 $0 (2024)
Amgen Inc. $429.69 3 $0 (2018)
Regeneron Pharmaceuticals, Inc. $262.83 2 $0 (2019)
AbbVie Inc. $177.99 8 $0 (2023)
Merck Sharp & Dohme LLC $116.08 6 $0 (2024)
Lilly USA, LLC $81.14 4 $0 (2024)
SHIELD THERAPEUTICS INC $49.65 2 $0 (2024)
GlaxoSmithKline, LLC. $22.91 1 $0 (2024)
PFIZER INC. $20.51 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $18.13 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $404.49 14 AstraZeneca Pharmaceuticals LP ($249.79)
2023 $213.99 10 AbbVie Inc. ($115.25)
2022 $99.06 5 ABBVIE INC. ($44.08)
2021 $18.66 1 AbbVie Inc. ($18.66)
2019 $133.23 1 Regeneron Pharmaceuticals, Inc. ($133.23)
2018 $254.60 2 Regeneron Pharmaceuticals, Inc. ($129.60)
2017 $794.55 6 AstraZeneca Pharmaceuticals LP ($489.86)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 2 of 2

Date Company Product Nature Form Amount Type
08/02/2022 Lilly USA, LLC Food and Beverage In-kind items and services $24.00 General
07/21/2022 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $14.80 General
Category: Diabetes
07/20/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $17.35 General
Category: NEUROSCIENCE
04/27/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $26.73 General
Category: NEUROSCIENCE
05/03/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $18.66 General
Category: NEUROSCIENCE
04/27/2019 Regeneron Pharmaceuticals, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $133.23 General
Category: INFLAMMATION AND IMMUNOLOGY
12/19/2018 Regeneron Pharmaceuticals, Inc. DUPIXENT DUPILUMAB INJECTION (Biological) Food and Beverage In-kind items and services $129.60 General
Category: INFLAMMATION AND IMMUNOLOGY
02/16/2018 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Cardiology
12/05/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $122.69 General
Category: Respiratory
12/01/2017 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $118.06 General
Category: Cardiology
11/29/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $123.84 General
Category: Respiratory
03/31/2017 Amgen Inc. Prolia (Biological) Food and Beverage In-kind items and services $186.63 General
Category: Endocrinology
02/23/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $124.97 General
Category: Respiratory
02/09/2017 AstraZeneca Pharmaceuticals LP BEVESPI AEROSPHERE (Drug) Food and Beverage In-kind items and services $118.36 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 39 2,478 4,539 $808,152 $349,415
2022 35 2,378 4,333 $734,866 $325,115
2021 41 2,956 5,349 $808,090 $410,629
2020 38 3,077 5,195 $682,749 $367,491
Total Patients
10,889
Total Services
19,416
Medicare Billing
$1.5M
Procedure Codes
153

All Medicare Procedures & Services

153 procedure records from CMS Medicare Utilization — Page 1 of 7

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 305 1,062 $159,150 $82,698 52.0%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 294 983 $147,450 $76,439 51.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 208 208 $37,440 $31,714 84.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 132 224 $40,320 $24,532 60.8%
93880 Ultrasound of both sides of head and neck blood flow Office 2023 105 105 $31,500 $19,185 60.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 122 248 $123,265 $18,321 14.9%
31231 Diagnostic exam of nasal passages using an endoscope Office 2023 44 44 $15,400 $7,901 51.3%
95923 Testing of autonomic (sympathetic) nervous system function Office 2023 64 65 $11,375 $7,691 67.6%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 41 41 $12,300 $7,666 62.3%
93922 Ultrasound study of arm and leg arteries Office 2023 105 105 $13,125 $7,616 58.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 38 40 $53,247 $6,402 12.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 35 55 $39,325 $6,066 15.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 77 78 $28,340 $5,747 20.3%
95921 Testing of autonomic nervous system function and heart rate response to deep breathing Office 2023 64 65 $7,800 $4,965 63.7%
93975 Complete ultrasound of abdomen and pelvis artery and vein blood flow Office 2023 17 17 $6,120 $4,267 69.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 53 68 $5,440 $3,349 61.6%
93970 Ultrasound study of arm or leg veins with compression and maneuvers Office 2023 16 16 $4,480 $2,979 66.5%
76700 Complete ultrasound scan of abdomen Office 2023 28 28 $4,760 $2,879 60.5%
31575 Diagnostic exam of voice box using a flexible endoscope Office 2023 22 22 $3,960 $2,736 69.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 25 25 $13,625 $2,689 19.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 29 29 $4,350 $2,583 59.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 256 504 $2,520 $2,470 98.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 20 20 $14,000 $2,444 17.5%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 12 12 $2,520 $2,347 93.1%
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle Office 2023 14 23 $3,450 $1,652 47.9%

About Dr. Leonid Volfinzon, M.D

Dr. Leonid Volfinzon, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952403933.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonid Volfinzon, M.D has received a total of $1,919 in payments from pharmaceutical and medical device companies, with $404.49 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,919).

As a Medicare-enrolled provider, Volfinzon has provided services to 10,889 Medicare beneficiaries, totaling 19,416 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Brooklyn, NY
  • Active Since 09/01/2006
  • Last Updated 03/19/2008
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1952403933

Products in Payments

  • BEVESPI AEROSPHERE (Drug) $489.86
  • Repatha (Biological) $243.06
  • FARXIGA (Drug) $204.76
  • Prolia (Biological) $186.63
  • UBRELVY (Drug) $149.11
  • DUPIXENT (Biological) $133.23
  • DUPIXENT DUPILUMAB INJECTION (Biological) $129.60
  • MOUNJARO (Drug) $57.14
  • BELSOMRA (Drug) $54.76
  • ACCRUFER (Drug) $49.65
  • BREZTRI (Drug) $45.03
  • QULIPTA (Drug) $28.88
  • LAGEVRIO (Drug) $25.18
  • TRELEGY ELLIPTA (Drug) $22.91
  • VERQUVO (Drug) $21.79
  • PAXLOVID (Drug) $20.51
  • CAMZYOS (Drug) $18.13
  • STEGLATRO (Drug) $14.35

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Brooklyn